128 related articles for article (PubMed ID: 31638218)
41. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
42. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
[TBL] [Abstract][Full Text] [Related]
43. Influence of the DCC gene on proliferation and carcinoembryonic antigen expression in the human colorectal cancer cell line SW1116.
Jiang HW; Wang J; Li HJ; Peng JK; Gao XP; Chen F
Genet Mol Res; 2015 Aug; 14(3):10273-80. PubMed ID: 26345965
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
45. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
Gong H; Cao Y; Han G; Zhang Y; You Q; Wang Y; Pan Y
Int J Oncol; 2017 May; 50(5):1785-1791. PubMed ID: 28339062
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.
Amankwatia EB; Chakravarty P; Carey FA; Weidlich S; Steele RJ; Munro AJ; Wolf CR; Smith G
Br J Cancer; 2015 Apr; 112(9):1480-90. PubMed ID: 25919696
[TBL] [Abstract][Full Text] [Related]
47. MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells.
Xiang KM; Li XR
Asian Pac J Cancer Prev; 2014; 15(8):3767-72. PubMed ID: 24870791
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, KRAS to paclitaxel treatment.
Fei BY; Wang XY; Fang XD
Tumour Biol; 2016 May; 37(5):5829-35. PubMed ID: 26581910
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1.
Shen H; Xing C; Cui K; Li Y; Zhang J; Du R; Zhang X; Li Y
Cell Death Differ; 2017 Jul; 24(7):1253-1262. PubMed ID: 28475173
[TBL] [Abstract][Full Text] [Related]
50. [Expression of miR-200a in colorectal carcinoma cell lines and its effect on LoVo cells].
Wu G; Zhao H; He N; Han H
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):450-4. PubMed ID: 25818799
[TBL] [Abstract][Full Text] [Related]
51. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs.
Pan Y; Liang H; Chen W; Zhang H; Wang N; Wang F; Zhang S; Liu Y; Zhao C; Yan X; Zhang J; Zhang CY; Gu H; Zen K; Chen X
RNA Biol; 2015; 12(3):276-89. PubMed ID: 25826661
[TBL] [Abstract][Full Text] [Related]
52. Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.
Wu PP; Jin YL; Shang YF; Jin Z; Wu P; Huang PL
Ann Clin Lab Sci; 2009; 39(3):263-9. PubMed ID: 19667410
[TBL] [Abstract][Full Text] [Related]
53. RegIV potentiates colorectal carcinoma cell migration and invasion via its CRD domain.
Guo Y; Xu J; Li N; Gao F; Huang P
Cancer Genet Cytogenet; 2010 May; 199(1):38-44. PubMed ID: 20417867
[TBL] [Abstract][Full Text] [Related]
54. Study of apoptosis-related interactions in colorectal cancer.
Arora H; Qureshi R; Rizvi MA; Shrivastava S; Parihar MS
Tumour Biol; 2016 Nov; 37(11):14415-14425. PubMed ID: 27629291
[TBL] [Abstract][Full Text] [Related]
55. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
56. MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo.
Vidic S; Markelc B; Sersa G; Coer A; Kamensek U; Tevz G; Kranjc S; Cemazar M
Cancer Gene Ther; 2010 Jun; 17(6):409-19. PubMed ID: 20094071
[TBL] [Abstract][Full Text] [Related]
57. Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas.
Gopalan V; Ebrahimi F; Islam F; Vider J; Qallandar OB; Pillai S; Lu CT; Lam AK
Exp Cell Res; 2018 Sep; 370(2):245-253. PubMed ID: 29958837
[TBL] [Abstract][Full Text] [Related]
58. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer.
Vakana E; Pratt S; Blosser W; Dowless M; Simpson N; Yuan XJ; Jaken S; Manro J; Stephens J; Zhang Y; Huber L; Peng SB; Stancato LF
Oncotarget; 2017 Feb; 8(6):9251-9266. PubMed ID: 27999210
[TBL] [Abstract][Full Text] [Related]
59. Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.
Zhang X; Zhang Y; Yang J; Li S; Chen J
Cancer Gene Ther; 2015 Oct; 22(10):475-80. PubMed ID: 26384136
[TBL] [Abstract][Full Text] [Related]
60. Pro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells.
Risberg K; Redalen KR; Sønstevold L; Bjørnetrø T; Sølvernes J; Ree AH
BMC Cancer; 2016 Jul; 16():531. PubMed ID: 27461218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
